Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- MXCT
- Price
- 1.25
- Stock movement up
- +0.02 (1.63%)
- Company name
- MaxCyte Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 133.34M
- Ent value
- 153.57M
- Price/Sales
- 3.87
- Price/Book
- 0.74
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 11.37%
- 1 year return (CAGR)
- -75.49%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
MXCT does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.87 |
| Price to Book | 0.74 |
| EV to Sales | 4.46 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 106.67M |
| EPS (TTM) | -0.43 |
| FCF per share (TTM) | -0.39 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 34.42M |
| Gross profit (TTM) | 28.61M |
| Operating income (TTM) | -49.99M |
| Net income (TTM) | -45.63M |
| EPS (TTM) | -0.43 |
| EPS (1y forward) | -0.27 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 83.11% |
| Operating margin (TTM) | -145.25% |
| Profit margin (TTM) | -132.57% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 12.97M |
| Net receivables | 8.31M |
| Total current assets | 124.64M |
| Goodwill | 3.55M |
| Intangible assets | 667.00K |
| Property, plant and equipment | 46.74M |
| Total assets | 213.48M |
| Accounts payable | 1.29M |
| Short/Current long term debt | 18.16M |
| Total current liabilities | 16.10M |
| Total liabilities | 33.20M |
| Shareholder's equity | 180.28M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -39.54M |
| Capital expenditures (TTM) | 1.68M |
| Free cash flow (TTM) | -41.23M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -25.31% |
| Return on Assets | -21.38% |
| Return on Invested Capital | -25.13% |
| Cash Return on Invested Capital | -22.70% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.25 |
| Daily high | 1.28 |
| Daily low | 1.23 |
| Daily Volume | 415K |
| All-time high | 17.20 |
| 1y analyst estimate | 6.68 |
| Beta | 0.32 |
| EPS (TTM) | -0.43 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| MXCT | S&P500 | |
| Current price drop from All-time high | -92.73% | -0.89% |
| Highest price drop | -92.97% | -19.00% |
| Date of highest drop | 20 Jan 2026 | 8 Apr 2025 |
| Avg drop from high | -84.85% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
133.34M
Marketcap category
Small-cap
Description
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Employees
114
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page